S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
S&P 500   3,798.91
DOW   30,930.52
QQQ   316.41
Log in
OTCMKTS:ENZN

Enzon Pharmaceuticals Stock Forecast, Price & News

$0.31
+0.01 (+3.83 %)
(As of 01/19/2021 03:59 PM ET)
Add
Compare
Today's Range
$0.29
Now: $0.31
$0.33
50-Day Range
$0.17
MA: $0.25
$0.35
52-Week Range
$0.02
Now: $0.31
$0.36
Volume50,777 shs
Average Volume663,207 shs
Market Capitalization$23.12 million
P/E RatioN/A
Dividend YieldN/A
Beta0.77
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in licensing drug products. Its marketed drug products include PegIntron and Sylatron. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

MarketRank

Overall MarketRank

0.56 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryBiotechnology
SectorMedical
Current SymbolOTCMKTS:ENZN
Previous SymbolNASDAQ:ENZN
CUSIP29390410
Phone732-980-4500
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$210,000.00
Book Value$0.14 per share

Profitability

Net Income$-980,000.00
Net Margins-1,711.94%

Miscellaneous

Market Cap$23.12 million
Next Earnings Date2/17/2021 (Estimated)
OptionableNot Optionable
$0.31
+0.01 (+3.83 %)
(As of 01/19/2021 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ENZN News and Ratings via Email

Sign-up to receive the latest news and ratings for ENZN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Enzon Pharmaceuticals (OTCMKTS:ENZN) Frequently Asked Questions

How has Enzon Pharmaceuticals' stock price been impacted by Coronavirus (COVID-19)?

Enzon Pharmaceuticals' stock was trading at $0.1693 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ENZN stock has increased by 84.0% and is now trading at $0.3115.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Enzon Pharmaceuticals?

Wall Street analysts have given Enzon Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Enzon Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Enzon Pharmaceuticals' next earnings date?

Enzon Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for Enzon Pharmaceuticals
.

How were Enzon Pharmaceuticals' earnings last quarter?

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) posted its earnings results on Thursday, April, 30th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. Enzon Pharmaceuticals had a negative return on equity of 20.29% and a negative net margin of 1,711.94%.
View Enzon Pharmaceuticals' earnings history
.

Are investors shorting Enzon Pharmaceuticals?

Enzon Pharmaceuticals saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 43,700 shares, an increase of 241.4% from the December 15th total of 12,800 shares. Based on an average daily volume of 574,200 shares, the days-to-cover ratio is presently 0.1 days.
View Enzon Pharmaceuticals' Short Interest
.

Who are some of Enzon Pharmaceuticals' key competitors?

What other stocks do shareholders of Enzon Pharmaceuticals own?

Who are Enzon Pharmaceuticals' key executives?

Enzon Pharmaceuticals' management team includes the following people:
  • Mr. Andrew Rackear J.D., CEO & Sec. (Age 67, Pay $173.51k)
  • Mr. Richard L. Feinstein, VP of Fin. & CFO (Age 78, Pay $160.88k)

What is Enzon Pharmaceuticals' stock symbol?

Enzon Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ENZN."

How do I buy shares of Enzon Pharmaceuticals?

Shares of ENZN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Enzon Pharmaceuticals' stock price today?

One share of ENZN stock can currently be purchased for approximately $0.31.

How big of a company is Enzon Pharmaceuticals?

Enzon Pharmaceuticals has a market capitalization of $23.12 million and generates $210,000.00 in revenue each year.

What is Enzon Pharmaceuticals' official website?

The official website for Enzon Pharmaceuticals is www.enzon.com.

How can I contact Enzon Pharmaceuticals?

Enzon Pharmaceuticals' mailing address is 20 Commerce Drive Suite 135, Cranford NJ, 07016. The biotechnology company can be reached via phone at 732-980-4500 or via email at [email protected]

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.